IRD Opus Genetics

Watchlist

1.260
+0.110+9.57%

Close Mar 21 16:00 ET

1.259
-0.001-0.10%

Post 18:46 ET

39.78MMarket Cap-1.16P/E (TTM)

About Opus Genetics Company

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Company Profile

SymbolIRD

Company NameOpus Genetics

Founded2018

CEODr. George Magrath, PhD

MarketNASDAQ

Employees14

Fiscal Year Ends12-31

Address8 Davis Drive,Suite 220

CityDurham

ProvinceNorth Carolina

CountryUnited States of America

Zip Code27709

Phone1-248-957-9024

Websitehttp://opusgtx.com

Company Executives

Name
Position
Salary

Dr. George Magrath, PhD
Director and Chief Executive Officer
2.67M

Nirav Jhaveri, C.F.A.,M.B.A.
Chief Financial Officer
--

Dr. Ashwath Jayagopal, PhD
Chief Scientific and Development Officer
--

Joseph K. Schachle
Chief Operating Officer
--

Amy Rabourn
Senior Vice President, Finance and Principal Accounting Officer
789.92K

Bernhard Hoffmann
Senior Vice President, Corporate Development
789.92K

Cam S. Gallagher
Chairman of the Board
174.62K

Dr. Benjamin R. Yerxa,PhD
Director and President
--

Dr. Adrienne L. Graves,PhD
Director
--

Dr. Jean Bennett, M.D.,Pd.D
Director
--

Susan K. Benton
Independent Director
135.34K

Dr. James S.J. Manuso, M.B.A.,PhD
Independent Director
154.81K

Sean Ainsworth
Lead Independent Director
149.56K

Richard J. Rodgers
Independent Director
899.08K

IRD Opus Genetics

About Opus Genetics Company

Company Profile

Company Executives

Market Insights